Cost-effectiveness analysis of linezolid compared with vancomycin for the treatment of nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus.

Authors :: Estes L
Orenstem R
Source :: Clinical therapeutics [Clin Ther] 2007 Apr; Vol. 29 (4), pp. 759-60; author reply 760-1.
Publication Year :: 2007

Subjects :: Acetamides economics
Anti-Bacterial Agents economics
Cost-Benefit Analysis
Humans
Linezolid
Methicillin Resistance
Oxazolidinones economics
Vancomycin economics
Acetamides therapeutic use
Anti-Bacterial Agents therapeutic use
Cross Infection drug therapy
Oxazolidinones therapeutic use
Pneumonia, Staphylococcal drug therapy
Staphylococcus aureus drug effects
Vancomycin therapeutic use

Tools